Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2019

Jul 2, 2019

30718_dirs_2019-07-02_bbc7ea90-9a3e-410d-adba-34b3788bddd4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-07-01

Reporting Person: VESSEY RUPERT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-01 Common Stock A 147.00 $0.00 Acquired 147.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-01 Stock Options (Right to buy) $209.26 A 588.00 Acquired 2029-10-25 Common Stock (588.00) Direct

Footnotes

F1: The option vests on 6/30/2029.